Gut Bacteria May Provoke Multiple Sclerosis

The gut microbiome has been implicated in several diseases and illnesses, making maintaining a healthy microbiome with balanced gut bacteria important for overall health. Several studies have suggested bacteria plays a key role in the development of incurable autoimmune diseases, such as multiple sclerosis (MS).
The exposure to certain gut bacteria may spur MS, especially during young adulthood, according to research published by the Proceedings of the National Academy of Sciences.
The authors found that age, gut bacteria composition, and several associated genes seem to play a role in causing MS. These factors were observed to have the most significant impact during earlier life.
The authors said that additional studies could lead to novel therapies that would kill harmful gut bacteria that cause MS, while also enhancing protective bacteria, according to the study.
“The findings could have therapeutic implications on slowing down MS progression by manipulating gut bacteria,” said study co-author Suhayl Dhib-Jalbut, MD.
In the study, the investigators genetically engineered mice to have human genes known to increase MS risk.
When engineered mice were living in a sterile environment, they did not develop MS.
However, when the mice were living in a normal environment and exposed to bacteria, they developed MS-like disease and inflammation in their bowels, according to the study.
Based on these findings, the authors hypothesize that gut bacteria are a significant risk factor for MS and can trigger its development.
Notably, adolescent mice were more likely to develop MS compared with older mice. The authors said this may indicate that the older animals developed immunity against the bacteria over time, according to the study.
Another study—published by Cell Reports—found 3 human gut microbes that may help treat autoimmune diseases such as MS. The authors of the study found that one of the bacteria was able to effectively suppress MS in the preclinical mouse models.
The bacteria, Prevotella histicola, was shown to cause a decrease in T cells and dendritic cells, while increasing macrophages in the mice, which suggests it could treat MS.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Most Popular

Related Articles

Survey participants reported need for better education on how brain atrophy affects multiple sclerosis progression and cognitive loss.
Fingolimod (Gilenya) found to significantly reduce the annualized relapse rate compared with glatiramer acetate among patients with relapsing-remitting multiple sclerosis.
A look at last week's top stories in the world of pharmacy.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.